Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?
Nature Clinical Practice Cardiovascular Medicine · 2004
DOI: 10.1038/ncpcardio0014 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Nature Clinical Practice Cardiovascular Medicine, 2004. Verfasst von Bernard Gersh. Beteiligte Einrichtung: Mayo Clinic College of Medicine, Rochester, MN 55905, USA. gersh.bernard@mayo.edu. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Defibrillators, Implantable. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Mayo Clinic College of Medicine, Rochester, MN 55905, USA. gersh.bernard@mayo.edu
Zitieren
APA
Gersh, B. (2004). Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?. Nature Clinical Practice Cardiovascular Medicine. https://doi.org/10.1038/ncpcardio0014
Vancouver
Gersh B. Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?. Nature Clinical Practice Cardiovascular Medicine. 2004. doi:10.1038/ncpcardio0014
BibTeX
@article{Gersh2004,
author = {Gersh, Bernard},
title = {Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?},
journal = {Nature Clinical Practice Cardiovascular Medicine},
year = {2004},
doi = {10.1038/ncpcardio0014}
}
EUVIMED